Imperial Oil Limited engages in exploration, production, and sale of crude oil and natural gas in Canada. The company operates in three segments: Upstream, Downstream and Chemical segments. The Upstream segment explores and produces crude oil, natural gas, synthetic crude oil, and bitumen. The Downstream segment transports and refines crude oil; blends refined products; and distributes and markets refined products. This segment also transports crude oil production and third-party crude oil to refineries by contracted and common carrier pipelines; owns and operates refineries; maintains a distribution system to move petroleum products to market by pipeline, tanker, rail, and road transport; owns and operates fuel terminals, natural gas liquids, and products pipelines in Alberta, Manitoba, and Ontario; markets petroleum products under the Esso and Mobil brands; and sells petroleum products, including fuel, asphalt, and lubricants to industrial and transportation customers, independent marketers, resellers, and other refiners, as well as the agriculture, residential heating, and commercial markets through branded fuel and lubricant resellers. The Chemical segment manufactures and markets aliphatic solvents, plasticizer intermediates, and polyethylene resins; and markets refinery grade propylene. It also provides petrochemicals. The company was incorporated in 1880 and is headquartered in Calgary, Canada. Imperial Oil Limited operates as a subsidiary of Exxon Mobil Corporation.
Donor Network West and UCSF Establish Scalable Model to Expand Real-Time Access to Viable Human Organs and Tissue for Research
PR Newswire · 3m ago
The Inner Circle acknowledges Elisa Peavey, DO as a Pinnacle Lifetime Member
PR Newswire · 3m ago
UNIVERSAL HEALTH SERVICES, INC. TO PRESENT AT GOLDMAN SACHS ANNUAL GLOBAL HEALTHCARE CONFERENCE
PR Newswire · 5m ago
First Horizon Corporation to Participate in the Morgan Stanley U.S. Financials Conference
PR Newswire · 5m ago
Carnival Corporation Notice of Data Breach
PR Newswire · 5m ago
CPC Biotech Collaborates with Multiply Labs to Advance Cell Therapy Automation
PR Newswire · 5m ago
Quote and historical data from Yahoo Finance. Delayed at least 15 minutes for non-index symbols. Provided for informational purposes only; not investment advice.